NCT07933458
A Study to Evaluate the Safety of Subunit Influenza Vaccine in People Aged 6 Months and Older
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Interventions modified
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Occurrence of AEs and ADRs
Timeframe: Within 28 days post-vaccination
Occurrence of SAEs
Timeframe: Within 28 days post-vaccination
Arms and interventions
Active Surveillance Group
Passive Surveillance Group
Biologicals: subunit influenza vaccine
Sites
1 site in 1 country
- Ganzhou Center for Disease Control and Prevention (Ganzhou Health Comprehensive Supervision and Law Enforcement Bureau)Ganzhou, Jiangxi, China